Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.

Zhan, Yu; Wu, Xueyuan; Zheng, Gang; Jin, Jingjing; Li, Chaofu; Yu, Guanzhen; Li, Wenfeng

Zhan, Yu; Wu, Xueyuan; Zheng, Gang; Jin, Jingjing; Li, Chaofu; Yu, Guanzhen; Li, Wenfeng.

Afiliación

Zhan Y; Department of Ultrasound, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, 325000, China.
Wu X; Department of Chemoradiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, 325000, China.
Zheng G; Department of orthopedics, The Second Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, 325000, China.
Jin J; Department of Chemoradiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, 325000, China.
Li C; Department of Oncology, Dalian Medical University, Dalian, Liaoning, 116000, China.
Yu G; Department of Oncology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. qiaoshanqian@aliyun.com.
Li W; Department of Chemoradiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, Wenzhou, 325000, China. lwf636350@126.com.

World J Surg Oncol ; 18(1): 318, 2020 Dec 04.

Article en En | MEDLINE | ID: mdl-33276775

Asunto(s)

Neoplasias Ováricas; Carcinoma Epitelial de Ovario; Femenino; Humanos; Fenotipo; Pronóstico; Prolina

Palabras clave

Cancer prognosis; Early growth response protein 1; Immunohistochemistry; N-cadherin; Ovarian cancer; Proline-rich protein 11

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: World J Surg Oncol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google